Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus

por Vladimir V. Salukhov, Tatiana Y. Demidova
Publicado 2016

Decrease of cardiovascular risk in patients with type 2 diabetes: review of the common strategies and clinical studies

por Vladimir V. Salukhov, Yurii Sh. Khalimov, Sergey B. Shustov, Dmitriy V. Kadin
Publicado 2018

SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients

por Vladimir V Salukhov, Yurii Sh. Khalimov, Sergey B. Shustov, Sergey I. Popov
Publicado 2021

Possibilities of metabolic surgery for the treatment of type 2 diabetes mellitus in patients with grade 1 alimentary obesity

por Vladimir V. Salukhov, Nikita S. Ilinskii, Evgenii V. Vasil'ev, Ruslan T. Sardinov, Dmitrii V. Gladyshev
Publicado 2018